ELDN
Eledon Pharmaceuticals, Inc.
$3.93
-0.04 (-1.01%)
At close · Jul 7
Market Cap
$324.96M
Shares
77,187,823
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
FY2016
Net Income
-$45.62M
-26.1%
FY2025
Diluted EPS
-$0.52
+21.2%
FY2025
Operating Cash Flow
-$62.34M
-31.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | $0 | $0 | — | — | — | |
| $69.93M | $66.27M | $51.96M | $30.31M | $27.08M | $23.74M | $6.13M | $8.13M | $6.82M | $2.02M | $3.19M | $32.64M | $14.58M | $12.2M | $7.37M | |
| $16.54M | $16.98M | $18.61M | $12.69M | $12.7M | $13.13M | $10.05M | $6.06M | $7.24M | $11.1M | $1.94M | $12.62M | $8.89M | $3.55M | $2.28M | |
| — | — | — | — | — | — | $5000 | $9000 | $11K | $22K | $35K | — | — | — | — | |
| — | — | — | — | — | $2.3M | $2.28M | — | — | — | — | — | — | — | — | |
| $86.47M | $83.25M | $70.58M | $43M | $88.43M | $36.87M | $18.47M | $16.05M | $14.06M | $13.12M | $5.13M | $45.26M | $23.46M | $15.75M | $9.65M | |
| — | — | — | -$43M | -$88.43M | -$36.87M | -$18.47M | -$16.05M | -$14.06M | -$13.12M | -$5.13M | -$45.26M | -$23.46M | -$15.75M | -$9.65M | |
| — | — | — | — | — | — | -$18.46M | -$16.04M | -$14.05M | -$13.1M | -$5.09M | — | — | — | — | |
| $3.93M | $4.22M | $3.92M | $2.67M | $462K | $7000 | $79K | $40K | -$5000 | $5000 | -$527K | — | $166K | $24K | — | |
| — | -$45.58M | -$35.75M | -$116.54M | -$87.97M | -$36.86M | -$23.22M | -$16.01M | -$14.07M | -$13.12M | -$5.66M | — | — | — | — | |
| — | $35K | $431K | $0 | $0 | -$2.35M | -$404K | — | — | — | $0 | $0 | $0 | $0 | — | |
| -$78.15M | -$45.62M | -$36.18M | -$116.54M | -$87.97M | -$34.51M | -$22.81M | -$16.01M | -$14.07M | -$13.12M | -$5.66M | -$45.09M | -$23.3M | -$15.73M | -$9.65M | |
| — | -$42.33M | -$31.99M | — | — | — | — | — | — | — | — | -$45.09M | -$23.3M | -$15.82M | -$9.68M | |
| -$78.2M | -$45.62M | -$36.18M | — | — | — | — | — | — | — | -$37.91M | -$45.14M | -$23.3M | -$15.73M | — | |
| USD/shares | — | -$0.52 | -$0.66 | -$4.73 | -$6.16 | -$2.33 | — | — | — | — | — | — | — | — | — |
| USD/shares | — | -$0.52 | -$0.66 | -$4.73 | -$6.16 | -$2.33 | — | — | — | — | — | — | — | — | — |
| shares | — | 81.84M | 48.54M | 24.62M | 14.29M | 14.82M | 1.45M | 655.53K | 500.3K | 259.87K | 21.26K | 1.25M | 359.4K | 23.11K | 17.3K |
| shares | — | 81.84M | 48.54M | 24.62M | 14.29M | 14.82M | 1.45M | 655.53K | 500.3K | 259.87K | 21.26K | 1.25M | 359.4K | 23.11K | 17.3K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.